1 Flashcards

1
Q

Alemtuzumab

A

Recombinant humanised monoclonal antibody
Anti-CD52
CD52 is found on most B cells, T cells, monocytes, macrophages and some granulocytes
Rx: CLL, multiple sclerosis
Caution: may cause transient and severe hypotension caution with IHD

May cause hypotension, infusion related reactions, profound lymphopenia, pancytopenia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Bevacizumab

A

Recombinant humanised
binds to VEGF inhibiting angiogenesis
Risk of heart failure
Hypertension, impaired wound healing, thromboembolic events,

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Blinatumomab

A

Recombinant, bispecific mAb
Binds to CD19 (B cells ) and CD3 (T cells)
Forms link that results in activation of T cells and the elimination of CD-19 positive B cells
Indicated: B cell ALL
Cytokine release syndrome, neurological toxicity, infection

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Brentuximab vedotin

A

Conjugte - toxic payload: chimeric antibody (CD30) + monomethyl auristatin E (MMAE) a microtubule poison > cell cycle arrest and apoptosis
Containdicated with bleomycin
Renal avoid: <30mL/min
Hepatic avoid: Child B and C
Peripheral neuropathy, infusion related, PML, pneumonitis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Cetuximab

A
Recombinant chimeric 
Binds to EGFR 
inhibits proliferation, 
Skin reactions: acne, rash,
infusion reaction, VTE, mucositis,
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

EGFR inhibitors

A
Cetuximab
Panitumumab
Afatinib
Erlotinib
Gefitinib
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

EGFR inhibitor skin reactions

A

Papulopustular rash
Face and upper body
Occurrence/severity may be associated with response to treatment
Rx doxycycline prophylaxis and steroids
Other skin signs: itch, dry skin, fissures, paronychia, nail disorders, abnormal hair growth

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Ipilimumab

A

Human monoclonal Ab

CTLA-4 (cytotoxic T lymphocyte-associated antigen 4

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

CYP450 inducers

A
SCRAP GPS
St. John's Wort
Carbamazipine
Rifampicin
Alcohol (chronic)
Phenytoin
Griseofulvin
Phenobarbital
Sulphonylureas
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

CYP450 inhibitors

A
SICKFACES.COM GQ
Sodium valproate
Isoniazid
Cimetidine
Ketoconazole
Fluconazole
Alcohol (acute)/amiodarone
Chloramphenicol
Erythromycin
Sulphonamides
Ciprofloxicin
Omeprazole
Metronidazole
Grapefruit juice
Quinidine
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Omalizumab

A

Recombinant humanised
Monoclonal antibody against IgE
Reduces the immune systems response to allergen exposure
Rx: asthma, chronic spontaneous urticaria
Thrombocytopenia, ? association with Churg-Strass syndrome
SE: injection site reactions, bleeding, headache, MSS pain, anaphylaxis , serum sickness-like reaction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Anti-CD20 antibodies

A

Rituximab
Ofatumumab
Obinutuzumab

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Basilixumab

A

Chimeric monoclonal antibody against IL-2
Blocks IL-2 inhibiting T-lymphocyte proliferation
Rx: prevention of acute renal transplant rejection (also liver and lung)
Caution if previous Rx with basilixumab, may increase risk of hypersensitivity; ?increase in surgical wound complications
SE: hypersensitivity, cytokine release syndrome

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Crizotinib

A

Tyrosine kinase inhibitor
Inhibits anaplastic lymphoma kinase (ALK) and hepatocyte growth factor (HGFR, c-Met)
Rx: anaplastic lymphoma (AKL +); non-small cell lung cancer (ALK+)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Afatinib

A

TKI
EGFR
HER2, HER4

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Axitinib

17
Q

Dasatinib

A
BCR-ABL
Src family
c-KIT
PDGFR
ephrin receptor
18
Q

Erlotinib

19
Q

Gefitinib

20
Q

Ibrutinib

A

Bruton’s tyrosine kinase (BTK)

21
Q

Imatinib

A

bcr-abl, c-KIT, PDGFR

22
Q

Nilotinib

A

bcr-abl, c-KIT, ephrin receptor, PDGFR

23
Q

Tofacitinib

A

JAK1, JAK2, JAK3

24
Q

Sunitinib

A

VEGFR 1-3
PDGFR
c-KIT
FLT-3

25
Sorafenib
``` VEGFR 2-3 PDGFR c-kit FLT-3 also Raf kinase ```
26
Pertuzumab
Recombinant humanised Monoclonal antibody against HER2 Prevents HER2 paring with other members of the HER family, arrests cell growth and induces apoptosis Activates immune response that lyses tumour cells Rx: HER2 positive breast cancer Caution: risk of cardiac failure/LV dysfunction caution if underlying heart disease, or other cardiotoxic agents SE: infusion related reactions, LV dysfunction, diarrhoea, oral mucositis, headache, neutropenia, rash, itch
27
Secukinumab
Recombinant human monoclonal antibody IL-17 Inhibits the activity of IL-17 which is involved in inflammatory and immune responses Rx: psoriatic arthritis, ankylosing spondylitis Caution with IBD, may cause new cases or exacerbate SE: menstrual disorders, infection, hypersensitivity reactions, neutropenia May develop anti-drug antibodies
28
Abiraterone
Inhibits CYP17 Results in reduction of androgen synthesis in testicular, adrenal and prostate tumour tissue Rx: prostate cancer May cause mineralocorticoid excess - give with supplemental prednisolone Caution if CVD, heart failure Contraindicated in severe liver impairment SE: fluid retention, hypokalaemia, hypertension, UTI, fracture, hot flushes
29
Methotrexate
Folic acid antagonist Inhibits DNA synthesis and cell replication by competitively inhibiting the conversion of folic acid to folinic acid Rx: cancer, psoriasis, RA, Crohn's Caution: immunosuppressive, GI ulcers, third spacing, hepatic and renal Teratogenic Toxicity: myelosuppression, pulmonary, hepatic
30
Cyclosporine
Calcineurin inhibitor Forms complex with cyclophilin which blocks the action of calcineurin in activated T cells. Prevents production of IL-2 and other cytokines Rx: transplant rejection, nephrotic syndrome, RA, psoriasis Caution: uncontrolled hypertension, renal impairment, immunosuppressive SE: "get more" gingival hyperplasia, hypertension, hypercholesterolaemia, hyperkalaemia, hyperglycaemia, raised bilirubin + aminotransferases BUT hypomagnesaemia Reversible posterior leucoencephalopathy syndrome Level C0 and C2, calculate AUC
31
Leflunomide
Inhibits pyramiding synthesis in leucocytes and other rapidly dividing cells by inhibiting activity of dihydro-orotate dehydrogenase Rx: RA, psoriatic arthritis Contraindicated: lymphoproliferative disease in last 5 years, myelodysplasia Infection (TB, HBV), ILD Hepatotoxic: avoid if ALT+AST >2 ULN Teratogenic SE: abdominal pain, cholelithiasis, ILD, hypersensitivity, peripheral neuropathy Washout-cholestyramine
32
Sulfasalazine
MOA is unclear Exerts local anti-inflammatory action on bowel wall Rx: UC, Crohn's (better for distal disease) Caution: G6PD deficiency, asthma Renal <20mL/min, hepatic clearance Safe in pregnancy, give folic acid supplement. SE: haemolytic, oligospermia, vomiting, yellow-orange discolouration of fluids, pancreatitis, interstitial nephritis.
33
Ustekinumab
Recombinant human monoclonal antibody Inhibits activity of cytokines, IL-12 and IL-23, which are involved in inflammatory and immune response Rx: chronic psoriasis, psoriatic arthritis if unresponsive to TNFa Caution: malignancy of history of malignancy, infection (TB, HBV) May exacerbate psoriasis or psoriatic arthritis SE: pustular psoriasis, exfoliative dermatitis, hypersensitivity, injection site reaction
34
Apremilast
Inhibits phosphodiesterase 4 Reduces proportion of pro-inflammatory cytokines (e.g. TNFa, IL-17, IL 23 and increasing anti-inflammatory cytokines (e.g. IL -10) Rx: chronic psoriasis, psoriatic arthritis Caution: depression Renal: <30mL/min Avoid pregnant SE: GI (esp. diarrhoea), depression, rebound psoriasis, weight loss
35
Cyclophosphamide
Alkylating agent Immunosuppressive properties are considered due to cytotoxic effect on lymphocytes Interfere with cellular replication by forming cross-linkages between DNA strands Rx: autoimmune disease, cancer, vasculitis Caution: myelosuppression, haemorrhaging cystitis, cardiotoxicity Teratogenic SE: alopecia, hyperpigmentation heart failure, pulmonary fibrosis, hyponatraemia + seizures
36
Mycophenolate
Mofetil and sodium are both converted to mycophenolic acid Selectively suppressed lymphocyte proliferation and antibody formation by inhibiting unisons monophosphate dehydrogenase Depletion of guanosine nucleotides results More lymphocyte selective than azathioprine Rx: prevent transplant rejection, autoimmune disease Caution: GI ulceration (increased risk bleeding), reduced absorption of MMF with low gastric acid (e.g. PPI use), use sodium in this context Renal: Teratogenic SE: myelosuppression, oesophagitis, gastritis, colitis, infection, aplastic anaemia, pure red cell aplasia, photosensitivity